Peter Niclas Broer

Dr. Peter Niclas Broer


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2023 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
SKSamuel Knoedler
Samuel Knoedler
MKMartin Kauke-Navarro
Martin Kauke-Navarro
LKLeonard Knoedler
Leonard Knoedler
SFSarah Friedrich
Sarah Friedrich
HAHaripriya S. Ayyala
Haripriya S. Ayyala
APAdriana C. Panayi
Adriana C. Panayi

Verified
Journal Article
Open access
PDF file
LKLeonard Knoedler
Leonard Knoedler
MMMaximilian Miragall
Maximilian Miragall
MKMartin Kauke-Navarro
Martin Kauke-Navarro
DODoha Obed
Doha Obed
MBMaximilian Bauer
Maximilian Bauer
AKAndreas Kehrer
Andreas Kehrer
Background: The grading process in facial palsy (FP) patients is crucial for time- and cost-effective therapy decision-making. The House-Brackmann scale (HBS) represents the most commonly used classification system in FP diagnostics. This study investigated the benefits of linking machine learning (ML) techniques with the HBS. Methods: Image datasets of 51 patients seen at the Department of Plastic, Hand, and Reconstructive Surgery at the University Hospital Regensburg, Germany, between June 2020 and May 2021, were used to build the neural network. A total of nine facial poses per patient were used to automatically determine the HBS. Results: The algorithm had an accuracy of 98%. The algorithm processed the real patient image series (i.e., nine images per patient) in 112 ms. For optimized accuracy, we found 30 training runs to be the most effective training length. Conclusion: We have developed an easy-to-use, time- and cost-efficient algorithm that provides highly accurate automated grading of FP patient images. In combination with our application, the algorithm may facilitate the FP surgeon’s clinical workflow.

1 January 2019 in Journal of Cranio-Maxillofacial Surgery
Verified
Journal Article
Closed access
Lukas PrantlLukas Prantl
Lukas Prantl
Paul HeidekruegerPaul Heidekrueger
Paul Heidekrueger
Peter Niclas BroerPeter Niclas Broer
Peter Niclas Broer
SKSebastian Knoll
Sebastian Knoll
ATAung Thiha
Aung Thiha
MGMartin Gründl
Martin Gründl

4 December 2023 in International Journal of Surgery
Verified
Journal Article
Open access
SKSamuel Alfons Christoph Knoedler
Samuel Alfons Christoph Knoedler
MKMartin Kauke-Navarro
Martin Kauke-Navarro
LKLeonard Knoedler
Leonard Knoedler
SFSarah Friedrich
Sarah Friedrich
DMDany Y. Ba Matar
Dany Y. Ba Matar
Adriana C PanayiAdriana C Panayi
Adriana C Panayi
Background: Breast cancer mortality and treatment differ across racial groups. It remains unclear whether such disparities are also reflected in perioperative outcomes of breast cancer patients undergoing mastectomy. Study design: The authors reviewed the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database (2008–2021) to identify female patients who underwent mastectomy for oncological purposes. The outcomes were stratified by five racial groups (white, Black/African American, Asian, American Indian/Alaska Native, and Native Hawaiian/Pacific Islander) and included 30-day mortality, reoperation, readmission, surgical and medical complications, and non-home discharge. Results: The study population included 222 947 patients, 68% (n=151 522) of whom were white, 11% (n=23 987) Black/African American, 5% (n=11 217) Asian, 0.5% (n=1198) American Indian/Alaska Native, and 0.5% (n=1018) Native Hawaiian/Pacific Islander. While 136 690 (61%) patients underwent partial mastectomy, 54 490 (24%) and 31 767 (14%) women received simple and radical mastectomy, respectively. Overall, adverse events occurred in 17 222 (7.7%) patients, the largest portion of which were surgical complications (n=7246; 3.3%). Multivariable analysis revealed that being of Asian race was protective against perioperative complications [odds ratio (OR)=0.71; P<0.001], whereas American Indian/Alaska Native women were most vulnerable to the complication occurrence (OR=1.41; P<0.001). Black/African American patients had a significantly lower risk of medical (OR=0.59; P<0.001) and surgical complications (OR=0.60; P<0.001) after partial and radical mastectomy, respectively, their likelihood of readmission (OR=1.14; P=0.045) following partial mastectomy was significantly increased. Conclusion: The authors identified American Indian/Alaska Native women as particularly vulnerable to complications following mastectomy. Asian patients experienced the lowest rate of complications in the perioperative period. The authors’ analyses revealed comparable confounder-adjusted outcomes following partial and complete mastectomy between Black and white races. Their findings call for care equalization in the field of breast cancer surgery.

29 May 2019 in Medicina
Verified
Journal Article
Open access
PDF file
JPJeremie Oliver Piña
Jeremie Oliver Piña
DBDaniel Boczar
Daniel Boczar
MHMaria T Huayllani
Maria T Huayllani
DRDavid J. Restrepo
David J. Restrepo
Andrea SistiAndrea Sisti
Andrea Sisti
Antonio Jorge ForteAntonio Jorge Forte
Antonio Jorge Forte
Background: In those undergoing treatment for breast cancer, evidence has demonstrated a significant improvement in survival, and a reduction in the risk of local recurrence in patients who undergo postmastectomy radiation therapy (PMRT). There is uncertainty about the optimal timing of PMRT, whether it should be before or after tissue expander or permanent implant placement. This study aimed to summarize the data reported in the literature on the effect of the timing of PMRT, both preceding and following 2-stage expander-implant breast reconstruction (IBR), and to statistically analyze the impact of timing on infection rates and the need for explantation. Methods: A comprehensive systematic review of the literature was conducted using the PubMed/Medline, Ovid, and Cochrane databases without timeframe limitations. Articles included in the analysis were those reporting outcomes data of PMRT in IBR published from 2009 to 2017. Chi-square statistical analysis was performed to compare infection and explantation rates between the two subgroups at p < 0.05. Results: A total of 11 studies met the inclusion criteria for this study. These studies reported outcomes data for 1565 total 2-stage expander-IBR procedures, where PMRT was used (1145 before, and 420 after, implant placement). There was a statistically significant higher likelihood of infection following pre-implant placement PMRT (21.03%, p = 0.000079), compared to PMRT after implant placement (9.69%). There was no difference in the rate of explantation between pre-implant placement PMRT (12.93%) and postimplant placement PMRT (11.43%). Conclusion: This study suggests that patients receiving PMRT before implant placement in 2-stage expander–implant based reconstruction may have a higher risk of developing an infection.

1 February 2024 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
SKSamuel Alfons Christoph Knoedler
Samuel Alfons Christoph Knoedler
LKLeonard Knoedler
Leonard Knoedler
BGBenedikt Geldner
Benedikt Geldner
IGIman Ghanad
Iman Ghanad
BKBong-Sung Kim
Bong-Sung Kim
APAngie M. Paik
Angie M. Paik